Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion
The optimal antithrombotic strategy following left atrial appendage occlusion (LAAO) is not yet clearly established. Low-dose non-vitamin K antagonist oral anticoagulants (NOAC) might represent a valid alternative, but data regarding their usage is scarce. The aim of this study was to examine the ef...
Guardado en:
Autores principales: | Pedro Luis Cepas-Guillen, Eduardo Flores-Umanzor, Ander Regueiro, Salvatore Brugaletta, Cristina Ibañez, Laura Sanchis, Marta Sitges, Josep Rodés-Cabau, Manel Sabaté, Xavier Freixa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5dfc3a33d4c74b4a9dab82beb028805c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long-term effect of anticoagulation following left atrial appendage occlusion with the LARIAT device in patients with nonvalvular atrial fibrillation: impact on thromboembolism, bleeding and mortality. Real life data
por: Radosław Litwinowicz, et al.
Publicado: (2020) -
Factores de riesgo para la formación de trombos sobre el dispositivo ULTRASEPT®, en pacientes con fibrilación auricular sometidos a cierre percutáneo de orejuela izquierda
por: Valdebenito,Martin, et al.
Publicado: (2016) -
Five-Year Outcomes and Cardiac Remodeling Following Left Atrial Appendage Occlusion
por: Liu B, et al.
Publicado: (2021) -
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
por: Liu Yaowu, et al.
Publicado: (2021) -
Periprocedural and Short‐Term Outcomes of Percutaneous Left Atrial Appendage Closure According to Type of Atrial Fibrillation
por: Toshiaki Isogai, et al.
Publicado: (2021)